Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery Finasteride, Placebo, Prostatectomy, Laboratory biomarker analysis NCT00438464 National Cancer Institute (NCI) Completed
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer placebo, genistein, laboratory biomarker analysis NCT00290758 National Cancer Institute (NCI) Completed
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade... placebo, defined green tea catechin extract, laboratory biomarker analysis NCT00303823 National Cancer Institute (NCI) Completed
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Therapeutic Conventional Surgery NCT00666562 National Cancer Institute (NCI) Completed
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT02237183 National Cancer Institute (NCI) Recruiting
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia placebo, inositol NCT00783705 National Cancer Institute (NCI) Completed
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current... Aspirin, Laboratory Biomarker Analysis, Placebo NCT02123849 National Cancer Institute (NCI) Completed
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer letrozole, quality-of-life assessment, laboratory biomarker analysis NCT01077453 National Cancer Institute (NCI) Completed
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers linaclotide acetate, placebo, pharmacological study, laboratory biomarker analysis NCT01950403 Mayo Clinic Completed

Pages